摘要
RNA干扰(RNAi)是双链RNA特异抑制靶基因表达的转录后基因沉默方式,以白血病特异性融合基因和白血病广谱表达的WT1基因为靶标的siRNA治疗是白血病基因治疗的有效方式之一。然而,RNAi应用于临床仍面临许多问题有待解决。
RNAi is double-strands RNA inhibiting specially target gene's expression and leads to post-transcript gene silence.SiRNA treatment targeted leukemia's fuse gene and WT1 gene which leukemia express universally,SiRNA treatment is a effective method for leukemia gene treatment.However,RNAi has lots of problems waiting for solution when it is used in clinic.
出处
《肿瘤研究与临床》
CAS
2007年第4期280-282,共3页
Cancer Research and Clinic